Palatin Technologies
PTN
$1.82
Share price
5.81%
Change (1 day)
-22.88%
Change (1 year)
Categories
Palatin Technologies (PTN) - Total assets
Total assets on the balance sheet as of December 2023 : $13.55 M
According to Palatin Technologies's latest financial reports the company's total assets are $13.55 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Palatin Technologies - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | $17.93 M | -50.27% |
| 2022-06-30 | $36.07 M | -46.4% |
| 2021-06-30 | $67.29 M | -20.88% |
| 2020-06-30 | $85.05 M | -18.79% |
| 2019-06-30 | $0.10 B | 168.44% |
| 2018-06-30 | $39.01 M | -31.35% |
| 2017-06-30 | $56.83 M | 423.42% |
| 2016-06-30 | $10.85 M | -63.16% |
| 2015-06-30 | $29.47 M | 134.69% |
| 2014-06-30 | $12.55 M | -49.91% |
| 2013-06-30 | $25.07 M | 366.02% |
| 2012-06-30 | $5.38 M | -74.59% |
| 2011-06-30 | $21.17 M | 70.9% |
| 2010-06-30 | $12.38 M | -6.14% |
| 2009-06-30 | $13.19 M | -30.98% |
| 2008-06-30 | $19.12 M | -55.3% |
| 2007-06-30 | $42.78 M | 6.83% |
| 2006-06-30 | $40.04 M | 13.88% |
| 2005-06-30 | $35.16 M | 26.5% |
| 2004-06-30 | $27.8 M | 22.35% |
| 2003-06-30 | $22.72 M | 83.85% |
| 2002-06-30 | $12.35 M | -13.24% |
| 2001-06-30 | $14.24 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 1,236,052.51% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 754,562.55% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $3.25 B | 23,887.07% | 🇺🇸 USA |
 MediciNova MNOV | $66.27 M | 388.90% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.78 B | 5,707.65% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $0.90 B | 6,572.34% | 🇺🇸 USA |
 GlycoMimetics
GLYC | $53.2 M | 292.49% | 🇺🇸 USA |
 Ardelyx ARDX | $0.29 B | 2,095.38% | 🇺🇸 USA |